MondelezAmbev
Live Report · Updated 7 August 2026

Mondelez vs Ambev

Global snacks and confectionery leader with strong brands vs Leading Latin American brewer with extensive distribution network. Which is the better buy for your portfolio in August 2026? Plain-English answer below.

Mondelez sells snack foods globally with iconic brands like Oreo and Cadbury that command pricing power even during inflationary periods, while Ambev dominates beer distribution across Latin America t...

Why It’s Moving

Mondelez

MDLZ stays in focus as analysts lean constructive, even as consumer staples sentiment stays mixed.

  • Analyst sentiment remains constructive, with most covering firms rating Mondelez at Buy or Overweight and consensus price targets clustered in the mid-to-high $60s, signaling expectations for steady upside rather than a sharp re-rating.
  • A recent Barclays target increase to $70 helped keep attention on the stock, suggesting analysts still see Mondelez as a defensive consumer name with durable earnings power even in a slower growth backdrop.
  • Broader analyst commentary has turned more cautious on consumer staples, with some firms trimming targets on muted volume growth and pricing, which can cap enthusiasm for packaged-food stocks despite Mondelez’s relatively stable outlook.
Sentiment:
⚖️Neutral
Ambev

Ambev is drawing attention as investors weigh a volume rebound against lingering margin pressure.

  • Ambev’s latest coverage points to a recovery in Brazil beer volumes in 2Q26, which would help offset earlier concerns about softer demand and industry weakness.
  • Citi said the company may be heading into a stronger quarter, suggesting investors are focused on whether volume momentum can translate into better earnings quality.
  • Broader macro noise is also in play, including competition, consumer spending trends, and World Cup-related demand expectations that could lift beverages but also raise comparison risks.
Sentiment:
⚖️Neutral

Investment Analysis

Pros

  • Mondelez has a diversified global presence with leading snack brands across multiple regions, supporting stable revenue streams.
  • The company maintains a strong balance sheet with moderate debt levels and consistent dividend payouts, appealing to income-focused investors.
  • Recent analyst consensus is positive, with a 'Buy' rating and an average price target suggesting potential upside over the next year.

Considerations

  • Profit margins have come under pressure, with net margins around 9.8%, which may constrain future earnings growth.
  • The stock has shown volatility over the past year, with a notable trading range, which could concern risk-averse investors.
  • Mondelez faces intense competition in the snack food sector, which may limit its ability to raise prices and maintain market share.
Ambev

Ambev

ABEV

Pros

  • Ambev benefits from a dominant position in the Brazilian beverage market, providing strong regional pricing power and brand loyalty.
  • The company has a history of efficient cost management and operational improvements, supporting profitability in challenging markets.
  • Ambev's diversified product portfolio includes both alcoholic and non-alcoholic beverages, reducing reliance on any single category.

Considerations

  • Ambev's financial performance is highly sensitive to economic conditions in Latin America, exposing it to regional volatility.
  • Currency fluctuations and inflation in key markets can impact margins and reported earnings for international investors.
  • Regulatory risks, including potential tax increases and advertising restrictions, could affect future growth prospects in its core markets.

Mondelez (MDLZ) Next Earnings Date

Mondelēz International’s next earnings report for MDLZ is scheduled for July 28, 2026. It will cover Q2 2026 results. If you are referring to the stock labeled “MDLZ Price Target 2026: Buy, Sell, or Hold? (Analyst Consensus),” the next earnings date is still the company’s Q2 2026 release, not a separate event.

Ambev (ABEV) Next Earnings Date

Ambev S.A. (ABEV) is expected to report next on July 30, 2026, based on the latest earnings calendar estimates. The release should cover Q2 2026 results. This date is still an estimate and can shift until the company formally confirms it.

Buy MDLZ or ABEV in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

MDLZ
MDLZ$62.61
vs
ABEV
ABEV$3.00
Buy MDLZ